IRIDEX Corporation (IRIX) Stock Analysis

IRIDEX Corporation (IRIX) is a publicly traded company in the HEALTHCARE sector. It trades at $1.17, carries a market capitalization of $19.32M. This page summarizes the public market data, fundamentals, and frequently asked questions for IRIX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.17
• Market Cap: $19.32M
• EPS: $-0.19
• 52-Week High: $1.65
• 52-Week Low: $0.87

Market Sentiment

IRIDEX Corporation currently has a Bullish sentiment score of 0.15.

About IRIDEX Corporation

IRIDEX Corporation (IRIX) is a prominent ophthalmic medical technology firm dedicated to the development and commercialization of advanced therapeutic laser systems and associated delivery devices for treating serious eye diseases. The company emphasizes enhancing patient outcomes in ophthalmology through a robust portfolio of consumable instrumentation that facilitates sophisticated ocular treatments. Headquartered in Mountain View, California, IRIDEX capitalizes on its innovative capabiliti...

GNG Research Analysis

GNG Research scores IRIDEX Corporation (IRIX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IRIX.

Frequently Asked Questions

Does IRIX pay dividends?

IRIDEX Corporation (IRIX) does not currently pay a regular dividend.

What is IRIX's market cap?

IRIDEX Corporation (IRIX) has a market capitalization of $19.32M with a current stock price of $1.17.